Two Oregonians have tested positive for a rare strain of Salmonella known as Salmonella overschie, according to the Oregon Health Authority Public Health Division. The first patient was a 28-year-old Coos County woman who fell ill in ...
Tags: Rare Salmonella, Coos County, patients, investigation
Transcatheter Technologies has announced that an independent laboratory has completed ‘advanced wear testing’ (AWT) of the company’s Trinity valve prosthesis, far exceeding minimum testing standards. Indeed, AWT of the ...
Tags: AWT, TAVI, PVL, Trinity valve
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today initiation of dosing in BLAST-AHF, the Company's randomized, multi-center ...
Tags: Trevena, GPCR biased ligands, BLAST-AHF, acute heart failure
US-based SynCardia Systems has announced the implantation of the 150th SynCardia temporary total artificial heart in 2013. The 150th SynCardia temporary total artificial heart has been implanted on 26 November 2013. In 2012, a total of ...
Tags: Heart Implant, Syncardia Systems
US-based Medtronic has announced that its Micra transcatheter pacing system (TPS) has been implanted in the first patient in Austria as part of the company’s multi-center global clinical trial. The single-arm, pivotal clinical trial ...
Posted in Printing Equipment and Supplies by Qmed Staff on November 25, 2013 Innovations in 3-D printing have allowed researchers to fabricate human bones, ears, early-prototype human hearts, strips of liver and face prosthetics. In the ...
W. L. Gore & Associates (Gore) has announced that Dr Brian Peterson from Saint Louis University, enrolled the first patient in the Gore EXCLUDER iliac branch clinical study. The clinical study is a prospective, multi-center, ...
Tags: Medicine, Gore Excluder
Medtronic has obtained an investigational device exemption from the US Food and Drug Administration (FDA) to initiate SYMPLICITY HTN-4 clinical trial using its Symplicity renal denervation system. SYMPLICITY HTN-4 study has been designed ...
Senesco Technologies reported the treatment of the first patient at the Company’s newly opened clinical-trial site at Seattle Cancer Care Alliance (SCCA). This patient is part of Senesco’s Phase 1b/2a clinical study of its ...
Tags: Senesco, Clinical Trial
Biotronik, a manufacturer of cardio and endovascular medical devices, has announced that its DREAMS scaffold (DRug Eluting Absorbable Metal Scaffold) has been successfully implanted in the first coronary artery disease patient in Germany as ...
Tags: Biotronik, medical devices
Vital Access, a provider of surgical and interventional technologies, has launched SAVE-2 post-market clinical follow-up study to investigate the benefits of VWING vascular needle guide for self-cannulation. The SAVE-2 study follows the ...
Spinal Modulation has enrolled the first patient in ACCURATE study, a prospective, randomized, multi-center, controlled trial designed to evaluate the safety and efficacy of the Axium neurostimulator system for the treatment of chronic ...
Tags: Spinal Modulation, treatment
Respicardia, a US-based developer of implantable therapies, has announced the enrollment of the first patients in the pivotal trial to evaluate the remede system in patients with central sleep apnea (CSA). The Respicardia pivotal trial is ...
Tags: Respicardia, Patient Enrollment
Northwestern's Bluhm Cardiovascular Institute has recently enrolled first patient in ABSORB III, a clinical trial to compare the performance of Abbott's drug eluting Absorb Bioresorbable Vascular Scaffold (BVS) device with other traditional ...
Tags: Absorb device, Medicine
Soft Tissue Regeneration has received a patent number 8,486,143 relating to the L-C Ligament, an investigational device for soft tissue regeneration of the anterior cruciate ligament (ACL) of the knee, from the US Patent and Trademark ...